Piscataway, NJ, 2023 – Sampled1 today announced that it has been named a Next-Generation Sequencing (NGS) ProLab for Twist Bioscience, a leading synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. As an NGS ProLab, Sampled can provide researchers and scientists with access to Twist […]
Partnerships
Sampled’s Genomics Laboratory in Glasgow Launches Inaugural Project with Guardant Health
Glasgow lab will manage blood samples for the Guardant Health SHIELD lung cancer screening study in the EU. February 1, 2023 – Piscataway, NJ – Sampled1 today announced that the new genomics Sampled SMART Lab in Glasgow, UK, has initiated a project with Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, to manage […]
Sampled at ISBER 2022
Sampled is honored to be presenting 4 talks and a poster at ISBER 2022. Take a sneak peak at the topics we will be covering at ISBER from innovative Biobanking strategies to generating high quality iPSC cell lines.
US launch of first polygenic test to predict risk of cognitive decline due to Alzheimer’s disease
Infinity BiologiX, Cytox, and Vanguard Pharma announce the US launch of the first, physician use only, polygenic test to predict the risk of cognitive decline due to Alzheimer’s disease.
